Detailed answers about CLINICAL TRIALS CONSULTING & TRAINING LIMITED, including incorporation, status, business activity, and accounts information.
When was CLINICAL TRIALS CONSULTING & TRAINING LIMITED founded?
CLINICAL TRIALS CONSULTING & TRAINING LIMITED was officially incorporated on 1 October 2007 and is registered under company number 06386114. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is CLINICAL TRIALS CONSULTING & TRAINING LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of CLINICAL TRIALS CONSULTING & TRAINING LIMITED?
CLINICAL TRIALS CONSULTING & TRAINING LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does CLINICAL TRIALS CONSULTING & TRAINING LIMITED do?
CLINICAL TRIALS CONSULTING & TRAINING LIMITED operates in the following sector: 74909 - Other professional, scientific and technical activities n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is CLINICAL TRIALS CONSULTING & TRAINING LIMITED's registered address?
The registered office address of CLINICAL TRIALS CONSULTING & TRAINING LIMITED is 53 PORTWAY, NORTH MARSTON, BUCKINGHAM, BUCKS, MK18 3PL. This is the official address filed with Companies House for legal and statutory correspondence.
Is CLINICAL TRIALS CONSULTING & TRAINING LIMITED financially stable?
The most recent accounts for CLINICAL TRIALS CONSULTING & TRAINING LIMITED were made up to 31 March 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 December 2026.